Comparison of complications after D2 and D3 dissection for gastric cancer

被引:0
作者
Bostanci, EB [1 ]
Yol, S [1 ]
Kayaalp, C [1 ]
Ozogul, Y [1 ]
Aydin, C [1 ]
Atalay, F [1 ]
Akoglu, M [1 ]
机构
[1] Turkiye Yuksek Ihtisas Hosp, Dept Gastrointestinal Surg, Ankara, Turkey
来源
EJSO | 2004年 / 30卷 / 01期
关键词
gastric cancer; gastrectomy; lymph node dissection; mortality; morbidity;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. D3 dissection is accepted as having higher rates of mortality and morbidity than D2 dissection. In this study, we aimed to evaluate the mortality and morbidity rates of D3 dissection in our department and to compare these with mortality and morbidity after D2 dissection. Patients and methods. All patients who underwent radical gastric resection with lymph node dissection for gastric adenocarcinoma between June 1999 and June 2002 were evaluated. Clinicopathologic features of the tumour, the resection and lymphadenectomy, the postoperative mortality and morbidity were analysed. Results. There were 359 patients admitted for the treatment of gastric cancer. One hundred twenty four underwent palliative resection and 134 underwent resection with curative intent. Of 34/134 patients, underwent gastric resection with D3 dissection, and 100 underwent D2 dissection. The overall operative mortality rate of D2 and D3 dissections was 1 and 8.8%, respectively (p < 0.05). The relaparotomy rate was almost doubled in D3 dissection group (11.8% vs. 6%) but this difference was not statistically significant. D3 dissection was also associated with an increase in morbidity (35.3% vs. 10%, p < 0.05). Conclusions. This study indicates that D3 dissection can be performed with reasonable safety. It may be a useful alternative procedure in advanced cases for which additional risks of surgical morbidity and mortality are felt to be outweighed by potential benefits to patients. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [41] Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery
    Kung, C-H
    Tsai, J. A.
    Lundell, L.
    Johansson, J.
    Nilsson, M.
    Lindblad, M.
    BJS OPEN, 2020, 4 (03): : 424 - 431
  • [42] Postoperative Chemoradiotherapy for Advanced Gastric Cancer after D2 Gastrectomy
    Deng, Xia
    Jin, Xiance
    Xue, Shengliu
    Zhang, Xuebang
    Su, Huafang
    Zhang, Ping
    Xie, Congying
    HEPATO-GASTROENTEROLOGY, 2014, 61 (133) : 1472 - 1477
  • [43] Impact of the introduction of formal D2 lymphadenectomy for gastric cancer in a Western setting
    Brind'Amour, Alexandre
    Gagne, Jean-Pierre
    Hogue, Jean-Charles
    Poirier, Eric
    CANADIAN JOURNAL OF SURGERY, 2021, 64 (02) : E119 - E126
  • [44] Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy
    Lee, Juhan
    Kim, Yoo-Min
    Woo, Yanghee
    Obama, Kazutaka
    Noh, Sung Hoon
    Hyung, Woo Jin
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2015, 29 (11): : 3251 - 3260
  • [45] Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection?
    Chang, Jee Suk
    Koom, Woong Sub
    Lee, Youngin
    Yoon, Hong In
    Lee, Hyung Sik
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (36) : 12900 - 12907
  • [46] Comparison of Standard D2 and Limited Lymph Node Dissection in Elderly Patients with Advanced Gastric Cancer
    Ko, Chang Seok
    Jheong, Jin Ho
    Jeong, Seong-A
    Kim, Byung Sik
    Yook, Jeong Hwan
    Yoo, Moon-Won
    Kim, Beom Su
    Lee, In-Seob
    Kim, Sehee
    Gong, Chung Sik
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (08) : 5076 - 5082
  • [47] D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery
    Jian-Kun Hu
    Kun Yang
    Bo Zhang
    Xin-Zu Chen
    Zhi-Xin Chen
    Jia-Ping Chen
    Surgery Today, 2009, 39 : 207 - 213
  • [48] Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study
    Brisinda, Giuseppe
    Chiarello, Maria Michela
    Crocco, Anna
    Adams, Neill James
    Fransvea, Pietro
    Vanella, Serafino
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (03) : 381 - 398
  • [49] Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer?
    Ibrahim Sakcak
    Baris Dogu Yildiz
    Fatih Mehmet Avsar
    Saadet Akturan
    Kemal Kilic
    Erdal Cosgun
    Enver O Hamamci
    World Journal of Gastroenterology, 2011, 17 (35) : 4007 - 4012
  • [50] Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer
    Ying Wu
    Zhe-Wei Wei
    Yu-Long He
    Roderich E Schwarz
    David D Smith
    Guang-Kai Xia
    Chang-Hua Zhang
    World Journal of Gastroenterology, 2013, (21) : 3309 - 3315